Europace (London, England), 2010-10, Vol.12 (10), p.1360-1420
- Camm, A John
- Kirchhof, Paulus
- Lip, Gregory Y H
- Schotten, Ulrich
- Savelieva, Irene
- Ernst, Sabine
- Van Gelder, Isabelle C
- Al-Attar, Nawwar
- Hindricks, Gerhard
- Prendergast, Bernard
- Heidbuchel, Hein
- Alfieri, Ottavio
- Angelini, Annalisa
- Atar, Dan
- Colonna, Paolo
- De Caterina, Raffaele
- De Sutter, Johan
- Goette, Andreas
- Gorenek, Bulent
- Heldal, Magnus
- Hohloser, Stefan H
- Kolh, Philippe
- Le Heuzey, Jean-Yves
- Ponikowski, Piotr
- Rutten, Frans H
2010
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Camm, A John
- Kirchhof, Paulus
- Lip, Gregory Y H
- Schotten, Ulrich
- Savelieva, Irene
- Ernst, Sabine
- Van Gelder, Isabelle C
- Al-Attar, Nawwar
- Hindricks, Gerhard
- Prendergast, Bernard
- Heidbuchel, Hein
- Alfieri, Ottavio
- Angelini, Annalisa
- Atar, Dan
- Colonna, Paolo
- De Caterina, Raffaele
- De Sutter, Johan
- Goette, Andreas
- Gorenek, Bulent
- Heldal, Magnus
- Hohloser, Stefan H
- Kolh, Philippe
- Le Heuzey, Jean-Yves
- Ponikowski, Piotr
- Rutten, Frans H
- Titel
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- Ist Teil von
- Europace (London, England), 2010-10, Vol.12 (10), p.1360-1420
- Ort / Verlag
- England: Oxford University Press
- Erscheinungsjahr
- 2010
- Quelle
- Oxford Journals 2020 Medicine
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1532-2092, 1099-5129eISSN: 1532-2092DOI: 10.1093/europace/euq350Titel-ID: cdi_swepub_primary_oai_DiVA_org_uu_137578
- Format
- –
- Schlagworte
- Acute Coronary Syndrome - epidemiology, Acute Coronary Syndrome - therapy, Acute Coronary Syndrome/epidemiology/therapy, Aged, Aldosterone Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors - therapeutic use, Anti-Arrhythmia Agents - therapeutic use, Anticoagulants - therapeutic use, Athletes - statistics & numerical data, Atrial Fibrillation - diagnosis, Atrial Fibrillation - epidemiology, Atrial Fibrillation - etiology, Atrial Fibrillation - physiopathology, Atrial Fibrillation - therapy, Atrial Fibrillation/diagnosis/epidemiology/etiology/physiopathology/therapy, Cardiomyopathy, Hypertrophic - epidemiology, Cardiovascular & respiratory systems, Comorbidity, Diabetes Mellitus - epidemiology, Electric Countershock - instrumentation, Electric Countershock - methods, Electric Countershock/instrumentation/methods, Female, Fibrinolytic Agents - therapeutic use, Heart Failure - drug therapy, Heart Failure - epidemiology, Heart Failure/drug therapy/epidemiology, Heart Rate - drug effects, Heart Rate - physiology, Heart Rate/drug effects/physiology, Heart Valve Diseases - epidemiology, Heart Valve Diseases - therapy, Heart Valve Diseases/epidemiology/therapy, Human health sciences, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Hyperthyroidism - epidemiology, Lung Diseases - epidemiology, Male, Middle Aged, Mineralocorticoid Receptor Antagonists - therapeutic use, Platelet Aggregation Inhibitors - therapeutic use, Pregnancy, Prevalence, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire, Wolff-Parkinson-White Syndrome - epidemiology